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INTRODUCTION
Cardiovascular disease morbidity and mortality rates have shown a dramatic decrease over the past 50 years due to advances in research and clinical care (Cutler et al., 2006; Lauer, 2012) . Nevertheless, heart disease remains the leading cause of death worldwide (Mathers and Loncar, 2006) . Cellular cardiomyoplasty has emerged as one of the most promising therapeutic approaches for treating ischemic heart disease since the last decade. Cellular transplantation has rapidly evolved from the benchside to clinical trials (Menasche, 2011) . In particular, mesenchymal stem cells (MSC) have shown promising results in improving cardiac function and attenuation of fibrosis (Tomita et al., 1999; Fazel et al., 2005) . However, the survival of the transplanted stem cells is limited not only due to the hypoxic environment of the myocardium, but also due to the abundance of oxidative stress and reactive oxygen species (ROS) in the infarcted heart (Zhang et al., 2001; Wei et al., 2010) . Oxidative stress has been implicated in the prognosis after an acute myocardial infarction particularly during the initiation of reperfusion, due to its direct cytotoxicity (Ferrari et al., 1985; Hill and Singal, 1996) , negative inotropism (Hill and Singal, 1996; Flesch et al., 1999) and pro-apoptotic effect (Krown et al., 1996; Ferrari et al., 2004) contributing to ventricular remodeling (Kinugawa et al., 2000) . β -blockers are commonly prescribed for patients with acute MI and they produce their effect by decreasing heart rate, myocardial contractility, myocardial oxygen consumption and the overall work load of the heart, hence improving ischemic heart symptoms (Monteiro et al., 2003; Kopecky, 2006) . Carvedilol (Carv) is a non-selective β -blocker with β 1, β 2 and α 1 adrenergic receptor blocking properties (Packer, 1998) , This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on April 28, 2017 jpet.aspetjournals.org anions and hydroxyl radicals (Yue et al., 1992; Feuerstein et al., 1998) . This dual property of Carv makes it substantially unique from drugs with only antioxidant properties. Furthermore, Carv attenuates cardiomyocyte apoptosis and the expression of pro-apoptotic proteins after ischemia reperfusion injury (Zeng et al., 2003) . The antiapoptotic cardioprotective role of Carv is independent of its anti-adrenergic properties (Schwarz et al., 2003) . Studies have shown that the antioxidant properties of Carv provide it a unique ability to maintain the viability and inhibit apoptosis in the ischemic myocardium (Cargnoni et al., 2000; Carreira et al., 2006) . Additionally, experimental studies have shown that Carv treatment alleviates left-ventricular remodeling, fibrosis and cardiac dysfunction in rats (Barone et al., 2007; Yoshikawa et al., 2010) .
Based upon the widespread use of Carv in hypertensive, post-MI and heart failure patients, the focus of this study was to see the combined effect of Carv in rats receiving MSC transplantation. Since, the morbidity and mortality rates after acute myocardial infarction have increased; it is clear that combination therapy utilizing complementary approaches would act synergistically to decrease further myocardial damage after MI. In the present study we have investigated the in-vitro protective effect 
METHODS
Chemicals
Carvedilol (Sigma Chemicals, St. Louis, MO) was freshly prepared in DMSO and diluted with PBS before administration. Xanthine and, xanthine oxidase were obtained from Sigma Chemicals (St. Louis, MO). DEPMPO (5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide) was obtained from Radical Vision (Jerome, Marseille, France). All other reagents were analytical grade or higher purchased from Sigma-Aldrich, unless otherwise mentioned.
Measurement of superoxide radicals by EPR spectroscopy
The superoxide radical-scavenging ability of Carv in vitro was determined by EPR spectroscopy . A mixture of xanthine (0.2 mM) and xanthine oxidase (0.02 U/ml) in PBS (pH 7.4) was used to generate superoxide radicals. EPR measurements were performed in PBS (pH 7.4) containing DEPMPO (1 mM) and in the presence or absence of different concentrations of Carv. The superoxide radicals were detected as DEPMPO-OOH adducts. The attenuation of DEPMPO adduct generation was quantified by double-integration and expressed as percentage of untreated (without Carv) levels.
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Cell survival and proliferation assay
MSCs (20,000/well) were cultured in a 96-well plate. After 24 h, the cells were treated with Carv (2.5 µM) or Atenolol (2.5 µM) for 1 h prior to the addition of 800-µM H 2 O 2 in a serum-free medium for 2 h. Controls were used in parallel for each treatment group. 0.5 mg/ml MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) in complete media was then applied to the cells for 2 h. The yellow tetrazolium MTT was reduced by metabolically active cells to a purple formazan which was solubilized and quantified by spectrophotometry at 570 nm and referenced higher than 650 nm. Similarly, anti-BrdU proliferation assay was performed. MSCs were incubated with 10-µM BrdU (5-bromo-2'-deoxyuridine) for 2 h. The pyrimidine analogue BrdU gets incorporated in place of thymidine into the DNA of active proliferating cell. The amount of BrdU utilized by the cells was assayed by ELISA technique using anti-BrdU antibody and its substrate.
Preparation of Carv suspension for oral administration
Based on the studies in the literature (Abdulla et al., 2011; Kumar et al., 2011) we have selected 5 mg/kg b.w. as the optimal dose to be administered daily to the rats following MI for 4 weeks. Coreg tablets were crushed to fine powder using a mortar and pestle and mixed with 20 ml of Ora-plus suspending agent to prepare a final concentration of 7.25 mg/ml of Carv suspension. The Carv suspension was prepared freshly every day prior to administration. . Rats were anaesthetized with ketamine (50 mg/kg, i.p) and xylazine (5 mg/kg, i.p) and maintained under anesthesia using isoflurane (1.5-2.0%) mixed with air.
Induction of myocardial infarction in vivo
Myocardial infarction (MI) was created by permanently ligating the left-anteriordescending coronary artery (LAD), as described previously . After permanent ligation of LAD, successful infarction was confirmed by an ST elevation on electrocardiograms that were recognized in all surgical groups of animals. MSCs or MSCs treated with Carv (2.5 µM) were transplanted in the ischemic heart at 30 min after permanent LAD ligation and the chest was closed. Shams (untreated animals) were anaesthetized as described previously and the chest cavity was opened and closed without LAD ligation. After re-initiation of spontaneous respiration, animals were extubated and allowed to recover from the anesthesia. The following day after surgery, 
Echocardiography (M-mode) for cardiac functional analysis
Assessment of cardiac function was performed at the baseline and at 4 weeks after MI or stem cell transplantation. Rats were anaesthetized using 1.5-2% isoflurane and Mmode ultrasound images were acquired using a Vevo 2100 (VisualSonics; Toronto, Canada) ultrasonic rodent imaging system as described previously (Khan et al., 2012) . 
Measurement of fibrosis
Rats were anaesthetized after 4 weeks of MI/stem cell transplantation, and their hearts were excised and washed with ice-cold PBS. The hearts were then frozen for 10-min at -20 o C and sliced into 2 mm sections using a heart matrix. The sections were then incubated in formalin overnight for Masson's trichrome staining for collagen/fibrosis. To determine the fibrosis, images were acquired by a dissecting microscope (Nikon; Tokyo, Japan). The fibrosis area was quantified by computerized planimetry using MetaMorph image analysis software (Molecular Devices; Sunnyvale, CA) as described previously ).
Assessment of apoptosis by TUNEL assay
To assess cell death or apoptosis, cultured MSCs/cryopreserved heart sections (5- using MetaMorph (Molecular Devices; Sunnyvale, CA) image analysis software as published earlier (Khan et al., 2010) .
Immunostaining for α -SMA and vWF
Immunostaining was performed in formalin fixed paraffin-embedded heart sections (5-micron). The fixed tissue sections were serially rehydrated as described previously (Khan et al., 2012 ). The tissue sections were then incubated with 2% goat serum and 
Western-blot analysis for molecular signaling
Western blots for pAkt, pERK1/2, Bcl-2 and caspase-3 signaling were performed with the tissue homogenates as described previously (Khan et al., 2012) . The anterior walls of the left ventricles were collected from Sham, MI, Carv, MSC and MSC+Carv groups.
After the treatment periods in all the groups, rats were anesthetized using pentobarbital sodium and the hearts were harvested and immediately rinsed in ice-cold PBS (pH 7.4).
The protein was separated by SDS-PAGE, transferred to polyvinylidene difluoride
This article has not been copyedited and formatted. The final version may differ from this version. for 1 h. The membranes were then washed and developed using an enhanced chemiluminescence detection system (ECL Advanced Kit, GE healthcare). The same membranes were then reprobed for GAPDH. The protein intensities were quantified by an image-scanning densitometer (Un-Scan It, UT). To quantify the phospho-specific signal in activated proteins, we first subtracted the background and then normalized the signal to the amount of GAPDH or total target protein in the tissue homogenate (Khan et al., 2012) .
DATA ANALYSIS
The statistical significance of the results was evaluated by one-way analysis of variance (ANOVA) and all pairwise multiple comparison procedures were done by Tukey's Post Hoc Test. The values were expressed as mean±S.D. A p value of <0.05 was considered significant.
RESULTS
Carv attenuates superoxide generation in vitro
To evaluate the superoxide scavenging property of Carv in vitro, we performed EPR spectroscopy. Detection of superoxide was performed by DEPMPO spin trap (1 mM) as DEPMPO-OO adduct. Carv significantly (p<0.05) reduced superoxide radical generation in vitro. Figure 1A shows representative spectra obtained by EPR spectroscopy. Figure   1B shows the scavenging effect of Carv against superoxide radicals. Carv (up to 1 mM), Figure 2C ).
Carv adjuvant treatment with MSC improves cardiac function
Cardiac function was measured at baseline and four weeks after MI by M-mode ultrasound echocardiography. Figure 3A shows representative images of M-mode echocardiography. The recovery of cardiac function was significantly (p<0.05) improved in in all treatment groups when compared to MI group. However, the functional recovery (ejection fraction and fractional shortening) was further improved in rats treated with MSC+Carv, when compared to MSC-alone group (p<0.05; Figure 3B & 3C). In addition, the LV inner diameters at end-systole (LVIDs) and end-diastole (LVIDd) were
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Carv and/or stem cells treatment ameliorates cardiac fibrosis
To further understand whether improved cardiac function correlates to cardiac fibrosis, masson-trichrome staining was performed for the assessment of fibrosis four weeks after MI. Data showed a significant (p<0.05) decrease in fibrosis in Carv, MSC and MSC+Carv treated groups, when compared to MI group ( Figure 4A) . Moreover, the fibrosis was significantly lower in Carv and MSC+Carv groups, when compared to MSCalone group. The fibrosis data supports our hypothesis that adjuvant treatment of MSCs with Carv attenuates cardiac fibrosis.
Carv and /or MSC treatment increases angiogenesis
To detect neovascularization in the infarcted heart, the cardiac tissue sections were stained with smooth muscle cell marker (α-SMA) and endothelial cell surface marker 
Carv and/or MSC treatment decreases myocardial apoptosis
One of the key events after acute MI; the apoptosis of cardiomyocytes is due to the activation of caspases that cleave DNA and other components. Apoptosis data in heart sections was evaluated at four weeks after MI by TUNEL assay. The data showed 
Carv adjuvant treatment with MSC attenuates caspase-3 expression in vivo
Caspase-3 expression was found to be significantly (p<0.05) decreased in rat hearts treated with Carv and MSC+Carv groups when compared with MI or MSC-alone groups ( Figure 5C ). The results indicate that Carv as an adjuvant treatment plays a crucial role in attenuating apoptosis of surviving myocytes in the infarcted area of the damaged heart. Since MSCs were pretreated with Carv prior to transplantation, and consecutively animals were treated with Carv daily for four weeks, this combined treatment might be responsible for significant decrease in caspase-3 expression in MSC and Carv combined group compared to MSC alone group.
Carv and MSC treatment modulates the phosphorylation of Akt, ERK1/2
PI3K-Akt signaling and ERK1/2 signaling cascades are activated due to a wide range of receptors and are involved in regulating cell survival, proliferation and differentiation (Widmann et al., 1999; Cross et al., 2000) . The results of our study showed a significant increase in phosphorylation of Akt and ERK1/2 in MI hearts when compared to all the treated groups. Interestingly, the levels of phospho-Akt and ERK1/2 were significantly downregulated (p<0.05) in Carv, MSC and MSC+Carv groups, when compared to MI group ( Figure 6 ).
DISCUSSION
Overall, the present study showed that the pretreatment of stem cells with Carv thereby suppressing apoptosis of surviving myocytes in the infarcted heart. The beneficial effects of Carv in protecting cardiomyocyte apoptosis and survival may seem to be due to its antioxidant properties.
Although, numerous pre-clinical studies have demonstrated the benefits of MSC therapy for treating the damaged heart after MI (Tomita et al., 1999; Kudo et al., 2003; Fazel et al., 2005) , one of the key factors that determine the clinical outcomes of transplanted stem cells is their survival in the ischemic heart. Previous studies from our group have shown that the important determinants that might affect the survival of stem cells in the ischemic heart are the apoptosis of transplanted cells due to low oxygen and oxidative stress Wisel et al., 2009) . Therefore, the main goal of this study was to understand whether pretreatment and/or post-conditioning of animals with Carv a non-selective β -blocker could improve the outcome of stem cell therapy.
Antioxidant effect of Carv on MSC in vitro
The potential sources of ROS in cardiomyocytes include mitochondrial electron transport chain, xanthine oxidase, non-phagocytic NADPH oxidases, dysfunctional NO synthase, lipoxygenase, heme-oxygenase and the cytochrome P450 monooxygenases. During cardiac disease the major sources of ROS in cardiac disease are the mitochondria, the xanthine oxidase and the NADPH oxidase (Grieve et al., 2004; Arozal et al., 2010) . One of the important observations of our study is the dosedependent increase in the superoxide-scavenging property of Carv compared to (Hayashi et al., 2010) . These dual properties of Carv distinguish it from drugs with only antioxidant properties.
Effect of Carv and MSC on cardiac function and fibrosis
Several pre-clinical studies have shown an improvement in cardiac function after MSC transplantation (Tomita et al., 1999; Kudo et al., 2003; Fazel et al., 2005) . However, this 
Effect of Carv and MSC on angiogenesis
We have previously reported that MSCs transplanted in the ischemic heart induce angiogenesis Khan et al., 2012) . The immunohistological findings from our current study showed an increased vessel and capillary density in the combined Carv and MSC group ( Figure 4B & 4C) . The results strongly suggest that the combinatorial treatment enhanced angiogenesis. However, the exact mechanism by which the combined treatment affects angiogenesis needs further investigation.
Effect of Carv and MSC on cardiomyocyte apoptosis and caspase-3 expression
One of the potential pathophysiological mechanisms in the progression of heart failure is cardiomyocyte apoptosis (Sabbah, 2000; Abbate et al., 2002) , which is responsible for cardiac cell loss after acute MI (AMI) (Olivetti et al., 1996) . This leads to changes in the shape, size and contractility of the left ventricle. Cardiac remodeling is not limited to the first 7 days after AMI; it is a progressive process which continues for weeks and up to several months after AMI Jessup and Brozena, 2003) . Studies in human post-mortem and animal tissues have demonstrated an increased rate of apoptosis in the peri-infarct and remote myocardium for several months after AMI (Palojoki et al., 2001; Baldi et al., 2002) . Apoptosis seemed to be higher in the periinfarct regions, particularly in cases of recurrent ischemia . A recent study by Abbate et al (Abbate et al., 2007) showed that permanent occlusion of infarctrelated artery (IRA) is associated with increased apoptosis of cardiomyocytes in the peri-infarct regions of the heart and persisted for up to 8 weeks after MI in an animal model of permanent occlusion of the left coronary artery . In the present study, we have shown that in animals treated with Carv and MSCs, there was a significant reduction in This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on April 28, 2017 jpet.aspetjournals.org Downloaded from apoptosis as indicated by decreased TUNEL positive cells . Additionally, caspase-3 which is an important mediator in regulating apoptosis was down-regulated in the combined treatment group . The results demonstrated that the decrease in apoptosis might be due to the synergism between the antioxidant properties of Carv and the paracrine signaling effect of MSCs ultimately leading to a decrease in cardiomyocytes apoptosis in the peri-infarct regions of the heart. Overall, the data demonstrates the significance of combined therapy with β -blocker (Carv) and stem cells for ameliorating myocardial apoptosis after AMI.
Effect of Carv and MSCs on phosphorylation of AKT and ERK
The increase in phosphatidylinositol-3-kinase/Akt (PI-3K/Akt) activation and extracellular signal-regulated kinase (ERK) pathways play an important role in the regulation of cardiomyocyte apoptosis and left-ventricular function (Li et al., 2009) . It has been reported that activation of ERK is associated with inhibition of cardiomyocyte apoptosis both in vitro and in vivo models of ischemia-reperfusion (Bueno et al., 2000; Foncea et al., 2000) . A study by Li et al (Li et al., 2009) showed an increase in ERK phosphorylation in saline-injected control hearts at 1 week after MI and this increase was considerably less pronounced in MSC transplanted hearts. Additionally, increased p-ERK1/2 activation was reported in infarcted and remote regions in the post-MI hearts . The study also suggested that the increase in MEK-1/ERK signaling may be predominantly localized in the non-myocytes in the scar and fibrotic regions.
Although, cardiomyocytes contribute to the majority of the adult myocardial mass, they comprise of only 30% of the total cells in the heart and the remaining being poised of non-myocyte cells (Zak, 1973) , these non-myocyte cells might be responsible for This article has not been copyedited and formatted. The final version may differ from this version. 
FIGURE LEGENDS
Figure1: Carvedilol attenuates superoxide radicals: Superoxide-scavenging ability of Carv was determined by EPR spectroscopy using DEPMPO spin trapping (A)
Representative EPR spectra of DEPMPO spin trap (1 mM) was used to detect of superoxide radicals as DEPMPO-OOH adduct. (B) 1 mM of Carv, challenged against 1-mM DEPMPO, decreased the intensity of the DEPMPO-OOH spectrum by more than 35%, which was not seen with Atenolol (B). Overall, the EPR data clearly established that the Carvedilol is capable of scavenging superoxide in a dose-dependent manner.
(NS represents not significant). Values are expressed as Mean ± SD; n=3. 
